Physician profile
Travis Moss
NPI 1225337785
$5,542.16
in general payments reported to CMS, 2019-2025
30 companies · $730 in 2025
The $730 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $91.46 · 2021: $75.45 · 2022: $282 · 2023: $2,118 · 2024: $1,958 · 2025: $730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,981 · Travel and Lodging: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,981.34 |
| Travel and Lodging | $824.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,339.05 | 2023-2024 | Pascal, Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $649.98 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $642.82 | 2019-2025 | |
| Amgen INC. | $504.02 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $473.59 | 2020-2025 | |
| Heartflow, INC. | $262.68 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $258.77 | 2019-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $175.78 | 2023-2024 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.04 | 2019-2025 | Jardiance |
| Impulse Dynamics (USA) INC. | $150.91 | 2023 | Optimizer |
| Boston Scientific Corporation | $125.64 | 2019-2024 | Watchman Access System |
| Merck Sharp & Dohme LLC | $91.50 | 2023-2024 | Verquvo |
| Cvrx, INC. | $81.25 | 2024 | Barostim Neo System |
| Baxter Healthcare | $79.67 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $64.49 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $62.67 | 2022-2024 | Amvuttra |
| Scpharmaceuticals INC. | $57.23 | 2024 | |
| Inspire Medical Systems, INC. | $52.07 | 2024 | Inspire |
| Astrazeneca Pharmaceuticals LP | $45.27 | 2020-2024 | Farxiga |
| Esperion Therapeutics, INC. | $37.36 | 2023-2025 | Nexletol |
| Janssen Pharmaceuticals, INC | $37.17 | 2024 | Xarelto |
| Abiomed | $30.94 | 2024 | Impella |
| Sanofi-Aventis U.S. LLC | $29.20 | 2019-2024 | |
| Novo Nordisk INC | $22.72 | 2024 | Rybelsus, Ozempic |
| Ossur Americas, INC. | $20.59 | 2025 | |
| Abbott Laboratories | $19.27 | 2024 | Mitraclip |
| Cleerly, INC. | $19.21 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Daiichi Sankyo INC. | $15.88 | 2024 | Injectafer |
| Terumo Medical Corporation | $15.74 | 2019 | |
| Ethicon US, LLC | $14.65 | 2025 | Dermabond Prineo, Ethicon, Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.